Table 2.

Pre and post treatment histology analysis.

Patient Number	Timepoint	Viral RNA* (SD)	Viral protein* (SD)	Caspase 3* (SD)	CD8* (SD)	PD L1** (SD)	IDO 1* (SD)
002	Pre	0	0	6.1 (2.8)	16.9 (6.6)	31.3 (6.6)	37.5 (10.9)
	Post	65.7% (8.3)	4.3% (3.1)	11.1 (5.5)	37.0 (11.9)	25.6 (9.6)	27.7 (13.9)
004	Pre	0	0	-	61.1 (13.3)	43.1 (7.9)	-
	Post	54.9% (7.9)	2.3% (0.9)	11.2 (4.4)	153.9 (11.3)	42.9 (8.8)	13.9 (3.9)
005	Pre	0	0	-	11.1 (4.4)	24.5 (4.4)	-
	Post	-	-	-	-	-	-
006	Pre	0	0	5.4 (2.3)	1.5 (1.2)	2.4 (0.8)	1.1 (0.5)
	Post	78.4% (7.4)	1.6 % (1.0)	26.6 (8.3)	2.0 (1.1)	4.4 (1.1)	4.4 (1.4)
007	Pre	0	0	1.9 (1.6)	11.1 (3.9)	10.1 (3.9)	2.9 (1.6)
	Post	75.9% (6.6)	0.5% (0.4)	3.9 (2.2)	15.3 (5.5)	16.9 (4.4)	4.7 (1.8)
010	Pre	0	0	2.0 (0.9)	13.3 (3.4)	13.1 (3.9)	2.9 (1.6)
	Post	-	-	-	-	-	-

^*number of positive cells per field (20X);

^**% of positive cells;

SD, Standard deviation;

- No tumor, fibrosis